Quality System Evidence and ISO 13485 Certificates in Belarus Registration

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

In registration in Belarus, an ISO 13485 certificate plays the role of proof of manufacturing quality capability, and its value depends on whether the scope of the certificate covers the product under application and the production site. A certificate whose scope does not cover them is, for practical purposes, the same as having submitted nothing at all.

In registration practice, the quality system is the element that follows the product through its entire lifecycle: the same system that supports the initial application later carries the change assessments, the post-market feedback and the renewal files. Evidence assembled carelessly for the registration keeps generating friction long after the certificate is granted, which is why scope, validity and site coverage deserve attention at the very beginning of the project.

2. Legal basis

RegulationNumber or identifierDate of publication or entry into forceKey provisions
On Preliminary Technical Work Prior to State RegistrationMinistry of Health No. 55 (amended by No. 120 of 2023-08-23)2015-04-23Registration dossier document list, including quality-related certificates
On State Registration (Re-registration) of Medical DevicesCouncil of Ministers No. 211 (6-1/55925)Effective 2026-05-01Registration procedure
Decision of the Council of the Eurasian Economic Commission on the Registration and Examination RulesNo. 462016-02-12Union pathway requirements on the quality system
List of institutional services—Current webpageThe expert body duties include document review and inspection of production sites of foreign manufacturers

3. Expert insights

Insight one: the certificate scope is the first checkpoint. Reviewers first check whether the product scope in the certificate annex and the site address cover the present application. GRZAN frequently encounters projects in which the group headquarters holds a certificate but the actual manufacturing entity does not, or in which the certificate covers product category A while the application concerns product category B. Problems of this kind are pointed out at the formal completeness stage, which means they waste time precisely when the clock of the procedure is already running.

Insight two: ISO 13485 is the common form, not the only form. The annex to No. 55 requires quality-related supporting documents, and an ISO 13485 certificate is the most widespread and most readily accepted vehicle. For domestic manufacturers, an equivalent certificate under the national standards system may apply. When preparing, enterprises should confirm which form of evidence is the most reliable for the country of the applicant entity and the product category concerned, rather than assuming that one document format fits every case.

Insight three: the system certificate and the production site inspection are complementary, not substitutes. Holding an ISO 13485 certificate does not necessarily exempt the manufacturer from a site inspection; conversely, having undergone an inspection does not remove the need for a certificate. Both may appear in the preliminary technical work at the same time. Enterprises should budget and schedule the two items separately, because assuming that one covers the other leads to planning errors that surface late in the procedure.

Insight four: the validity period of the certificate must cover the review cycle. If the certificate expires during the 90 calendar days of preliminary technical work, the manufacturer will be asked to provide proof of renewal or to complete the review within the validity period. Enterprises should check the expiry date before submission and, where necessary, complete the renewal before filing, since a certificate that lapses mid-review suspends progress on the quality evidence entirely.

Insight five: the certificate is read together with the rest of the quality evidence. Where the site register lists several manufacturing addresses, reviewers check that the applied product is released at an address covered by the certificate; where subcontractors appear in the design or sterilization chain, their processes should be traceable within the quality system as well. A certificate that is formally valid but leaves key operations outside its scope creates questions that take longer to answer than obtaining a corrected scope in advance would have taken.

4. Practical recommendations

  1. Check the three consistencies before submission. The certificate holder matches the actual applicant, the product scope on the certificate matches the product applied for, and the site on the certificate matches the actual production site.
  2. Schedule renewal before submission. If the certificate expires within the review window, renew it first and then file.
  3. Budget the certificate and the site inspection as separate items. Do not assume that holding a certificate removes the inspection.
  4. Submit the certificate annexes, not only the main page. The scope information sits in the annexes; submitting only the main page leads to a formal rejection.

5. Verification checklist

  • □ The three consistencies of certificate holder, product scope and site have been checked
  • □ The certificate validity covers the review cycle, with renewal completed beforehand where necessary
  • □ The certificate annexes containing the scope information have been submitted
  • □ The system certificate and the production site inspection have been budgeted as separate items
  • □ The quality-related documents have been prepared according to the requirements of the annex to No. 55

Regulatory information verified as of October 30, 2026.

In the Eurasian Economic Union market, the core capabilities of GRZAN concentrate on three points. First, distinguishing between the two channels of Union-wide registration and national registration in each member state, including their applicable conditions and remaining time windows. The national registration procedure of Belarus has been fully restructured by Council of Ministers Resolution No. 211 of April 28, 2026 (state register number 6-1/55925, effective May 1, 2026), which compressed the total time limit for preliminary technical work to 90 calendar days, applied a closed list that the implementing organization is prohibited from expanding, while applications under the national procedure face the key deadline of December 31, 2027, so pathway selection must be decided in sync with the time window. Second, local authorized representative services, acting as the legal representative of the manufacturer in Belarus, handling registration submission, responses to technical queries, changes to the registration dossier, and post-market reporting obligations; GRZAN has updated its coordination mechanisms after Council of Ministers Resolution No. 378 of July 27, 2026 (effective July 30, 2026) transferred adverse event functions to the state institution Gosfarmnadzor. Third, quality system and testing support, assisting in establishing a quality management system compliant with ISO 13485 and organizing the technical documentation according to the target pathway: for the national pathway, the annex to Ministry of Health Resolution No. 55; for the Union pathway, Decision No. 46 of the Council of the Eurasian Economic Commission.

Business inquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail